Effects of pranlukast, a cysteinyl leukotriene receptor 1 antagonist, combined with inhaled beclomethasone in patients with moderateor severe asthma
- 31 August 2001
- journal article
- clinical trial
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 87 (2) , 156-161
- https://doi.org/10.1016/s1081-1206(10)62212-0
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Seven cases of complete and incomplete forms of Churg-Strauss syndrome not related to leukotriene receptor antagonistsJournal of Allergy and Clinical Immunology, 1999
- Worldwide Clinical Experience With the First Marketed Leukotriene Receptor AntagonistChest, 1997
- Oral and inhaled corticosteroids reduce bone formation as shown by plasma osteocalcin levels.American Journal of Respiratory and Critical Care Medicine, 1995
- The effect of an oral leukotriene antagonist, ONO-1078, on allergen-induced immediate bronchoconstriction in asthmatic subjectsJournal of Allergy and Clinical Immunology, 1993
- Hypothalamo-pituitary-adrenal axis suppression in asthmatics inhaling high dose corticosteroidsRespiratory Medicine, 1991
- Inhaled budesonide and behavioural disturbancesThe Lancet, 1991
- Inhibition of Exercise-Induced Bronchoconstriction by MK-571, a Potent Leukotriene D4–Receptor AntagonistNew England Journal of Medicine, 1990
- Effect of high dose inhaled beclomethasone dipropionate on carbohydrate and lipid metabolism in normal subjects.Thorax, 1987
- The effect of synthetic leukotrienes on tracheal microvascular permeabilityProstaglandins, 1983
- Leukotrienes are potent constrictors of human bronchiNature, 1980